Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase

• Published in: Journal of clinical microbiology 2024-06, Vol.62 (6), p.e0013624
• Main Authors: Moore, Hannah P, Palumbo, Philip J, Notarte, Kin Israel, Fogel, Jessica M, Cummings, Vanessa, Gamble, Theresa, Del Rio, Carlos, Batey, D Scott, Mayer, Kenneth H, Farley, Jason E, Remien, Robert H, Beyrer, Chris, Hudelson, Sarah E, Eshleman, Susan H
• Format: Article
• Language: English
• Subjects: Clinical Microbiology; Drug Resistance, Viral - genetics; Genotype; Genotyping Techniques - methods; High-Throughput Nucleotide Sequencing - methods; HIV Infections - virology; HIV Integrase - genetics; HIV Protease - genetics; HIV Reverse Transcriptase - genetics; HIV-1 - classification; HIV-1 - drug effects; HIV-1 - enzymology; HIV-1 - genetics; HIV-1 - isolation & purification; Humans; Mutation; Reagent Kits, Diagnostic - standards; RNA, Viral - genetics; Virology
• ISSN: 0095-1137; 1098-660X; 1098-660X
• DOI: 10.1128/jcm.00136-24

HIV genotyping is used to assess HIV susceptibility to antiretroviral drugs. The Applied Biosystems HIV-1 Genotyping Kit with Integrase (AB kit, Thermo Fisher Scientific) detects resistance-associated mutations (RAMs) in HIV protease (PR), reverse transcriptase (RT), and integrase (IN). We compared results from the AB kit with results obtained previously with the ViroSeq HIV-1 Genotyping System. DNA amplicons from the AB kit were also analyzed using next-generation sequencing (NGS). HIV RNA was extracted using the MagNA Pure 24 instrument (Roche Diagnostics; 96 plasma samples, HIV subtype B, viral load range: 530-737,741 copies/mL). FASTA files were generated from AB kit data using Exatype (Hyrax Biosciences). DNA amplicons from the AB kit were also analyzed by NGS using the Nextera XT kit (Illumina). Drug resistance was predicted using the Stanford HIV Drug Resistance Database. The mean genetic distance for sequences from ViroSeq and the AB kit was 0.02% for PR/RT and 0.04% for IN; 103 major RAMs were detected by both methods. Four additional major RAMs were detected by the AB kit only. These four major RAMs were also detected by NGS (detected in 18.1%-38.2% of NGS reads). NGS detected 27 major RAMs that were not detected with either of the Sanger sequencing-based kits. All major RAMs detected with ViroSeq were detected with the AB kit; additional RAMs were detected with the AB kit only. DNA amplicons from the AB kit can be used for NGS for more sensitive detection of RAMs.